These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30066026)

  • 21. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gain of function mutation and inflammasome driven diseases in human and mouse models.
    Cordero MD; Alcocer-Gómez E; Ryffel B
    J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoinflammatory retinopathy in chronic infantile neurological cutaneous and articular (CINCA) syndrome.
    Tran T; Moloney T; Adams MK; Shah SP
    J AAPOS; 2016 Aug; 20(4):365-8. PubMed ID: 27320017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1β Enhances Wnt Signal by Inhibiting DKK1.
    Yoshida Y; Yamasaki S; Oi K; Kuranobu T; Nojima T; Miyaki S; Ida H; Sugiyama E
    Inflammation; 2018 Oct; 41(5):1945-1954. PubMed ID: 29956067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cryopyrine-associated periodic syndrome: CAPS seen from adulthood].
    Koné-Paut I
    Rev Med Interne; 2015 Apr; 36(4):277-82. PubMed ID: 25595876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
    Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
    Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
    Ting TV; Scalzi LV; Hashkes PJ
    Pediatr Neurol; 2007 May; 36(5):338-41. PubMed ID: 17509468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
    Idorn L; Vissing NH; Jensen L; Herlin T
    Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
    Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome.
    Kilic H; Sahin S; Duman C; Adrovic A; Barut K; Turanli ET; Yildirim SR; Kizilkilic O; Kasapcopur O; Saltik S
    Eur J Paediatr Neurol; 2019 May; 23(3):466-472. PubMed ID: 30967326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome.
    Adán A; Solé M; Corcostegui B; Navarro R; Burés A
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CINCA Syndrome With New NLRP3 Mutation and Unreported Complication of Thyroid Carcinoma.
    Salehzadeh F; Barak M; Hosseiniasl S; Shahbazfar E
    Clin Med Insights Case Rep; 2019; 12():1179547619854705. PubMed ID: 31217698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.
    Russo RA; Melo-Gomes S; Lachmann HJ; Wynne K; Rajput K; Eleftheriou D; Edelsten C; Hawkins PN; Brogan PA
    Rheumatology (Oxford); 2014 Apr; 53(4):665-70. PubMed ID: 24352339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
    Youm YH; Nguyen KY; Grant RW; Goldberg EL; Bodogai M; Kim D; D'Agostino D; Planavsky N; Lupfer C; Kanneganti TD; Kang S; Horvath TL; Fahmy TM; Crawford PA; Biragyn A; Alnemri E; Dixit VD
    Nat Med; 2015 Mar; 21(3):263-9. PubMed ID: 25686106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.